XSHG
688799
, Last price
Name
Hunan Warrant Pharmaceutical Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
2.57
Vol. 1Y
—
Shs. 5Y
5.89%
Rev. 5Y
9.78%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.52b
+7.26%
Net income
241m
+46.95%
CFO
300m
+111.07%
Dividend
Jul 01, 20260.1788 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hunan Warrant Pharmaceutical Co., Ltd. is engaged in the manufacturing and commercialization of pharmaceutical products. Its extensive product line encompasses treatments addressing immune and kidney-related conditions, obstetrics and gynecology, cardiovascular health, and digestive system issues. The company also offers a range of anti-infective medications and remedies for various other ailments. Established in 2001, it is headquartered in Changsha, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||